Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Hadassah Pioneer of Open Heart Surgery and Heart Transplants Shares Autobiography

Prof. Joseph Borman, Hadassah Medical Center cardiothoracic surgeon, who performed Israel's first heart transplant, tells the story of his personal and professional life in a newly published autobiography, entitled Open Hearts: Memoirs of a Cardiac Surgeon.

Originally from South Africa, Prof. Borman, who lives in Jerusalem with his wife, Ruth, of 58 years, had visited the Hadassah Medical Center during a trip to Israel to see a 10th anniversary of Independence exhibition. He met with then Deputy Director General Dr. Jack Karpas, a former South African, who immediately offered Prof. Borman a position in cardiothoracic surgery. Prof. Borman went on to serve as head of Hadassah's Cardiothoracic Surgery Department for 25 years.

Heart disease is the leading cause of death among women in the United States. "Every Beat Counts—Hadassah's Heart Health Program" events from coast to coast raise public awareness and educate women about the risk factors for heart disease and how to reduce them.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

His second heart transplant patient, still living at the publication of the book, is one of the longest surviving heart transplant patients in the world. The patient's tradition has been to call Prof. Borman before each Jewish New Year and Passover holiday to wish him well.

 

In his autobiography's epilogue, Prof. Borman, now 85, writes: "I wish to be remembered as an individual who carried out his allotted time on this earth to the best of his ability in the most humane fashion."

Read more in The Jerusalem Post

Date: 3/20/2014


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America